Amin Ataie

Amin Ataie

Auto-generated profile, based on publicly available information

Amin Ataie

Department of Toxicology and Pharmacology, School of Medicine, Babol University of Medical Science, Babol, Iran

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
AAAmin Ataie
Amin Ataie
MSMasoumeh Sabetkasaei
Masoumeh Sabetkasaei
Abbas HaghparastAbbas Haghparast
Abbas Haghparast
AMAkbar Hajizadeh Hajizadeh Moghaddam
Akbar Hajizadeh Hajizadeh Moghaddam
BKBehrang Kazeminezhad
Behrang Kazeminezhad

15 March 2012 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
ZMZahra Mansouri
Zahra Mansouri
MSMasoumeh Sabetkasaei
Masoumeh Sabetkasaei
FMFatemeh Moradi
Fatemeh Moradi
FMFatemeh Masoudnia
Fatemeh Masoudnia
AAAmin Ataie
Amin Ataie

1 August 2010 in Journal of Medicinal Food
Verified
Journal Article
Closed access
AAAmin Ataie
Amin Ataie
MSMasoumeh Sabetkasaei
Masoumeh Sabetkasaei
Abbas HaghparastAbbas Haghparast
Abbas Haghparast
AMAkbar Hajizadeh Hajizadeh Moghaddam
Akbar Hajizadeh Hajizadeh Moghaddam
RARamin Ataee
Ramin Ataee
SMShiva Nasiraei Moghaddam
Shiva Nasiraei Moghaddam
Aging is the major risk factor for neurodegenerative diseases and oxidative stress and is involved in their pathophysiology. Oxidative stress can induce neuronal damage and modulate intracellular signaling, ultimately leading to neuronal death by apoptosis or necrosis. In this study we investigated the neuroprotective properties of the natural polyphenolic antioxidant compound, curcumin, against homocysteine (Hcy) neurotoxicity. Curcumin (5, 15, or 45 mg/kg) was injected intraperitoneally once daily for a period of 10 days beginning 5 days prior to Hcy (0.2 μmol/μL) intracerebroventricular injection in rats. Biochemical and behavioral studies, including passive avoidance learning and locomotor activity tests, were evaluated 24 hours after the last injection of curcumin or vehicle. Results indicated that Hcy induces lipid peroxidation and increases malondialdehyde (MDA) and superoxide anion (SOA) levels in whole rat brain. In addition, Hcy impaired memory retention in the passive avoidance learning test. However, curcumin treatment significantly decreased MDA and SOA levels and improved learning and memory in rats. These results suggest that Hcy may induce lipid peroxidation in rat brain and that polyphenol treatment (curcumin) improves learning and memory deficits by protecting the nervous system against oxidative stress.

1 January 2013
Verified
Journal Article
Open access
AAAmin Ataie
Amin Ataie
RARamin Ataee
Ramin Ataee
ZMZahra Mansoury
Zahra Mansoury
MAMohsen Aghajanpour
Mohsen Aghajanpour
Parkinson's disease is a degenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of this cell death is unknown. Homocysteine (Hcy) is a non-protein amino acid. It is a homologue of the amino acid cysteine. The elevated levels of homocysteine in plasma have been associated with a number of disease states. Hcy (2 µmol / µl) was injected intracerebroventricular (i.c.v) in rats, five days later, the locomotor activity was measured with open field apparatus, Also apoptosis was investigated in substantia nigra cells by immunohistochemical analysis. Hcy could decrease locomotor activities significantly in rats as well as it could induce apoptosis in substantia nigra cells. These results suggest that Hcy is a neurotoxic metabolite and may induce cell death in some nuclei in the brain.

1 January 2015
Verified
Journal Article
Open access
MSMohammad Shadifar
Mohammad Shadifar
RARamin Ataee
Ramin Ataee
AAAmin Ataie
Amin Ataie
AGAli Morad Heydari Gorgi
Ali Morad Heydari Gorgi
NNNafiseh Nasri Nasrabadi
Nafiseh Nasri Nasrabadi
SNSomayyeh Nouri
Somayyeh Nouri
Gastric adenocarcinoma is one of the most common malignancies worldwide. Many ethological causes have been introduced among which helicobacter pylori, as a gram-negative bacterium has been considered as an important pathological facilitating factor. This agent is also associated with different digestive diseases, such as gastritis, peptic ulcer, and mucosa-associated lymphoid tissue lymphoma. Recently, scientists have been described some molecular aspects that show the role of some apoptotic genes and proteins; for example: P53, Bcl2, C-Myc and Rb-suppressor systems in the H. pylori pathogenesis. Also the relationship between nitric oxide (NOSi genotype) with H. pylori infection has been shown. The aim of this mini-review is to explain better these genetically aspects of H.pylori pathogenesis.

4 March 2024
Verified
Book Chapter
Open access
PDF file
PSParisa Saberi-Hasanabadi
Parisa Saberi-Hasanabadi
MFMilad Esmaeilzadeh Farmad
Milad Esmaeilzadeh Farmad
AAAmin Ataie
Amin Ataie
RARamin Ataee
Ramin Ataee
Pain management in cancer patients is one of the main components of palliative treatment. The requirement for rational use of opioids is careful selection of patients, correct prescription of these compounds, compliance with drug dosage, regular sequence of use, compliance with side effects, and drug interactions. Most cancer patients with moderate to severe pain will respond to treatment with opioid analgesics. Limited comprehensive studies have been conducted so far on the use of opioids in cancer pain management. In this chapter, databases for the search included PubMed, MedLine, and Embase databases along with reviews and cross-references. We examine the continuous use of opioids and the related consequences and challenges in the management of patients with cancer pain. In addition, the discussion includes the therapeutic use of opioids, the effectiveness of treatment with this group of compounds, the assessment of the risk of continuous opioid use, and the guidance for administration of opioids in patients with cancer. In general, the effects of opioid use in different age groups with on cancer progression, metastases, and recurrence can be an interesting indication that is worth future research in case of loss of analgesic response in time.